Linden Advisors’s MetLife MET Stock Holding History

Linden Advisors’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-531,000	Closed	-$24.4M	–	138
2018 Q1	$24.4M	Buy	+531,000	New	+$25.8M	0.58%	54

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Linden Advisors's MET Position: Q2 2018 in Review

Linden Advisors sold out of MetLife (MET) in Q2 2018, closing a stake of 531,000 shares — an estimated $24.4M sold.

Linden Advisors first reported a position in MET in Q1 2018 and held it in 1 quarter. The position peaked at $24.4M in Q1 2018. 1,030 funds tracked by Wall St. Rank hold MET as of Q2 2018.

Linden Advisors reported no remaining MetLife position as of Q2 2018 after selling out during the quarter.
Linden Advisors sold 531,000 MetLife shares in Q2 2018, an estimated $24.4M.
Linden Advisors first reported a position in MetLife in Q1 2018 and held it in 1 quarter.
Linden Advisors's MetLife position peaked at $24.4M in Q1 2018.
1,030 funds tracked by Wall St. Rank held MetLife as of Q2 2018.

Based on Linden Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.